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Ngn3 is recognized as a regulator of pancreatic endocrine formation, and Notch signaling as an
important negative regulator Ngn3 gene expression. By conditionally controlling expression of Ngn3
in the pancreas, we ﬁnd that these two signaling components are dynamically linked. This connection
involves transcriptional repression as previously shown, but also incorporates a novel post-
translational mechanism. In addition to its ability to promote endocrine fate, we provide evidence of
a competing ability of Ngn3 in the patterning of multipotent progenitor cells in turn controlling the
formation of ducts. On one hand, Ngn3 cell-intrinsically activates endocrine target genes; on the other,
Ngn3 cell-extrinsically promotes lateral signaling via the Dll14Notch4Hes1 pathway which sub-
stantially limits its ability to sustain endocrine formation. Prior to endocrine commitment, the Ngn3-
mediated activation of the Notch4Hes1 pathway impacts formation of the trunk domain in the
pancreas causing multipotent progenitors to lose acinar, while gaining endocrine and ductal,
competence. The subsequent selection of fate from such bipotential progenitors is then governed by
lateral inhibition, where Notch4Hes1-mediated Ngn3 protein destabilization serves to limit endocrine
differentiation by reducing cellular levels of Ngn3. This system thus allows for rapid dynamic changes
between opposing bHLH proteins in cells approaching a terminal differentiation event. Inhibition of
Notch signaling leads to Ngn3 protein stabilization in the normal mouse pancreas explants. We
conclude that the mutually exclusive expression pattern of Ngn3/Hes1 proteins in the mammalian
pancreas is partially controlled through Notch-mediated post-translational regulation and we demon-
strate that the formation of insulin-producing beta-cells can be signiﬁcantly enhanced upon induction
of a pro-endocrine drive combined with the inhibition of Notch processing.
& 2013 Elsevier Inc. All rights reserved.Introduction
Diabetes results from insufﬁcient insulin signaling in response
to blood glucose. Islet cell replacement therapy promises a future
restoration of normal glycemic control in diabetic patients.
Although cadaveric islet cell transplantation is currently possible,
the scarcity of human donors has highlighted the need of an
unlimited islet cell source. Promising ﬁndings highlight the
possibility of converting adult cells into islet cells via somatic
cell reprogramming (Zhou et al., 2008), or alternatively directingll rights reserved.
tute, Cleveland Clinic, 9500
36 5454.the differentiation of pluripotent embryonic stem (ES) cells to
islet cells (D’Amour et al., 2006). Whether the objective is to
create replacement cells in-vivo or ex-vivo, the methodology relies
on our current understanding of the formation and patterning of
the pancreas during embryogenesis.
Genetic studies in mice have provided evidence that all
endocrine cells in the pancreas are formed from a progenitor cell
that has expressed the gene Ngn3 (Gradwohl et al., 2000). Ngn3 in
the mouse has a temporal expression pattern that increases from
embryonic day 9.5 (E9.5) and culminates at E13.5–14.5 where
after expression decreases and approaches undetectable levels at
birth (Gradwohl et al., 2000; Schwitzgebel et al., 2000). A number
of experimental evidence attests to the pro-endocrine effects of
Ngn3. During directed differentiation of human embryonic
stem cells, NGN3 is expressed prior to the detection of
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Ngn3 in mouse ES cells enhanced endocrine cell formation (Treff
et al., 2006). Ngn3 expression can be reactivated following partial
pancreatectomy (Li et al., 2010) and in duct-ligated adult mouse
pancreas. In the duct-ligated model, Ngn3-expressing cells can be
traced from adult pancreatic epithelial cells, puriﬁed, and
observed to adopt an endocrine cell fate including insulin-
producing beta-cells (Xu et al., 2008). Additional pro-endocrine
effects of Ngn3 was observed in virus-mediated gene delivery to
pancreatic ductal cells (Noguchi et al., 2006; Heremans et al.,
2002), and in the liver when Ngn3 is coordinately expressed with
Pdx1 (Yoon, 2007). Ngn3 is therefore capable of partially inducing
an endocrine program in hepatic progenitors (Yechoor et al.,
2009).
While Ngn3 has been recognized as a ‘master regulator’ of
endocrine cell formation (Rukstalis and Habener, 2009), its
expression per se is not sufﬁcient for endocrine fate speciﬁcation,
rather the right dosage of Ngn3 is critical to secure the endocrine
fate (Wang et al., 2010). Lineage tracing of Ngn3-expressing WT
cells have been shown to give rise to few acinar and ductal cells in
addition to the predominantly endocrine lineage contribution
(Gu et al., 2002; Schonhoff et al., 2004). Recent lineage tracing
of hypomorphic Ngn3 cells suggest that these non-endocrine
Ngn3-expressing descendants may be the result of cells that failed
to achieve the required threshold of Ngn3 for the endocrine fate,
as Ngn3 heterozygous, or Ngn3-deﬁcient, cells have an increased
propensity to adopt acinar and ductal fates (Wang et al., 2010;
Beucher et al., 2011).
Furthermore, while the endocrine inducing properties of Ngn3
makes it a promising molecular factor for the creation of insulin
producing cells, ectopic expression of Ngn3 in the mouse pan-
creas and in chick endoderm has been shown to cause a
predominant increased glucagon cell formation but not the other
endocrine cell types (Schwitzgebel et al., 2000; Apelqvist et al.,
1999; Grapin-Botton et al., 2001). This appears to be rooted in a
change in competence of Ngn3þ cells in a time-dependent
manner. Utilizing a tamoxifen-controlled Ngn3 gain-of-function
approach competence for the beta cell fate was only observed at,
and beyond the E12.5 time point, thus coinciding with the onset
of the secondary transition (Johansson et al., 2007).
As a means to investigate the ability of Ngn3 to promote
pancreatic insulin-type cells, and address the molecular mechan-
isms that may explain the change in competence of the Ngn3-
expressing cells, we created a conditional model of Ngn3 over-
expression using a tetracycline transactivator-regulatory system.
Utilizing the Pdx1-tTA TetOFF driver, we ﬁnd that in absence of
doxycycline, this transgenic model system is sufﬁciently powerful
to induce a widespread endocrine cell conversion within the
distal foregut segment effectively depleting the pancreatic/ante-
rior duodenal segment progenitors. Bypassing this early effect
through gestational timed intra-peritoneal doxycycline administra-
tions we here describe the phenotypes of delayed activation of Ngn3
in pancreas. Unexpectedly, we found that conditionally activating
Ngn3 prior to the secondary transition does not lead to increased
beta cell formation, but the induction of pancreatic ductal cells with
interspersed, glucagon-producing endocrine cells.
Mechanistically, we show that this experimental outcome
resulted from a Ngn3-mediated change in the patterning of
multipotent pancreatic progenitor cells (MPCs). Ectopic activation
of Ngn3 leads to activation of Dll1, thus leading to cell extrinsic
activation of Notch within the MPC population. These data are
consistent with recent observations clarifying a role of Notch
during tip/trunk patterning of the MPC population (Afelik et al.,
2012; Cras-Meneur et al., 2009; Horn et al., 2012; Schaffer et al.,
2010; Shih et al., 2012), where Notch signaling is needed for TrPC
(Trunk-Progenitor Cell) formation directly via Nkx6.1 activation(Afelik et al., 2012). Our ﬁndings reveal that the previously
observed gestational change in competence of Ngn3-expressing
cells is a result of the pancreas undergoing TipPC/TrPC patterning
as a prelude to the secondary transition and that Notch signaling
establishes competence for the beta cell fate. Importantly, our
data also uncovers a novel involvement of Notch signaling in the
control of Ngn3 protein dynamics. We demonstrate the Notch, via
Hes1, controls the stability of Ngn3 protein. This additional post-
translational control of Ngn3 decay helps explain the observed
preservation of a mutually exclusive Hes1/Ngn3 expression pat-
tern in both the Tet-regulated transgenic model as well as in the
WT pancreas. These ﬁndings provides a conceptual platform in
which rapid-change dynamics of an oscillating bHLH pair con-
sisting of Ngn3 and Hes1 is linked to the possible simultaneous
allocation of endocrine and ductal fates from a more homogenous
Notch-active TrPC population.Materials and methods
Animals
A linearized fragment containing pTRE2-Ngn3FLAG was used
for oocyte injection, and founder lines were established. Func-
tional testing was performed by intercrossing to the Pdx1-tTA
transgenic knock-in line, allowing identiﬁcation of four lines all of
which provided similar phenotypes.Embryonic studies and conditional gene activation
Gestational day 0.5 (E0.5) was deﬁned as the day of vaginal
plug detection. To temporarily allow for suppression of transgenic
(TG) expression, doxycycline (Dox) was administered (0.05 mg/g
body weight) as once-daily intraperitoneal (i.p.) injections at
times noted. Throughout, control littermates either of WT, or
single transgenic (STG) for the pTRE2-Ngn3 genotype were used
for comparative analysis. In all studies, these developed like WT
embryos. Embryonic genotypes were deﬁned by PCR on limb/paw
tissue.Histology, immunohistochemistry and microscopy
Mouse tissue: for each analysis, at least n¼3 double transgenic
(DTG) type pancreatic, or dissected distal foregut/midgut regions
were compared to at least 3 littermate controls (for speciﬁc
numbers, see supp. Table S1). Endodermal tissues were ﬁxed in
4% paraformaldehyde (PFA) at 4 1C for 12–24 h. PFA-ﬁxed speci-
mens were equilibrated in 30% sucrose in PBS at 4 1C overnight,
transferred to a 1:1 mixture of 30% sucrose in PBS:OCT for 4 h,
hereafter transferred to OCT overnight and subsequently embe-
dded in OCT by slow freezing. For immunoﬂuorescence staining,
sections were dried at 37 1C and microwave treated followed by
washing and blocking. Primary antibodies were applied overnight at
4 1C. Next day, secondary antibodies were applied for 1 h at room
temperature. Following washing, slides were mounted.Pancreatic explants and DAPT treatment
The dorsal pancreatic rudiment of E12.5 mouse embryos was
removed in cold PBS and transferred to a tissue culture ﬁlter
insert system. Pancreatic explants were treated with N-(S)-phe-
nyl-glycine-t-butyl ester (DAPT) (Sigma) in DMSO diluted in
medium to ﬁnal concentrations of 5–100 mM. Cultures were
incubated at 37 1C for 4 days and medium was changed daily.
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Quantitative morphometry of various cell types were per-
formed as described (Kobberup et al., 2010). The relative cellular
area was measured using ImagePro Software (Media Cybernetics,
Bethesda, MD). Student’s t-test (two-tailed) was used to deter-
mine statistical signiﬁcance and signiﬁcance was regarded as
pr0.05.
Quantitative real time RT-PCR (qRT-PCR)
Total RNA was isolated from dissected pancreas, treated with
DNase and reverse-transcribed using Superscript II (Invitrogen).
Quantitative real time PCR was performed using an ABI 7500 Real
Time PCR System. Primer sequences are available upon request.
The relative concentration of RNA for each gene to GAPDH was
determined using the DDCT method.Results
Ectopic Ngn3 expression leads to accelerated endocrine
differentiation at the expense of pancreatic progenitors
To explore the possibility of enhancing the induction of
pancreatic b cell fate over other fates such as a cells through
temporal control of Ngn3 overexpression, we created a doxycy-
cline inducible Ngn3 transgenic mouse, pTRE2-Ngn3. These mice
were generated by pro-nuclear injections with a linearized pTRE2-
Ngn3 DNA construct. Following transgenic founder screening
using a RIP-rtTA TetON driver line and Doxycycline (Dox) provi-
sion (supp. Fig. S1A–F), we used a TetOFF Pdx1-tTA knock-in line
(Pdx1-tTAKI, (Holland et al., 2002) and supp. Fig. S1G–I) to evaluateFig. 1. Ngn3-mediated pancreatic progenitor depletion due to endocrine differentiation.
of WT (B) and Ngn3 ON (C) pancreas/stomach/spleen/duodenum. Complete pancreatic
antral, and anterior duodenum. (D–M) immunoﬂuorescence analysis, dorsal pancreatic
expressing progenitor cells (D) into glucagon-expressing endocrine cells (E) is accompa
DTG (G) pancreas, but not in WT (F). Loss of multipotent pancreatic progenitors is ev
Mucin1 (Muc1, (H)) is also not detected in DTG pancreas (I). Nkx6.1 is detected in WT
Ngn3 (compare to (G)).the effect of ectopic Ngn3 expression within the Pdx1 domain in
the developing foregut. In control experiments with continuous
Dox administration to pregnant females, Pdx1-tTAKI;pTRE2-Ngn3
crosses revealed complete inactivity of the transgene at all ages
studied (data not shown).
Ectopic Ngn3 gene induction was achieved by omitting
Dox in the drinking water (Fig. 1A). Double-transgenic Pdx1-
tTAKI;pTRE2-Ngn3 embryos (Ngn3 ON) harvested at gestational
day 18.5 (E18.5) displayed signiﬁcant pancreatic hypoplasia as
previously reported for ectopic Ngn3 expression in the Pdx1
domain (Fig. 1C, (Apelqvist et al., 1999)), with the exception that
we observed a more pronounced hypoplasia of the pancreas, as well
as a loss of gut continuity at the antral stomach/duodenal level
(Fig. 1C). In this study, we focus on the effect of Ngn3 overexpression
on the developing pancreas; the effects within the lateral duodenal
wall and developing stomach will be described elsewhere.
The Ngn3-mediated pancreatic organ hypoplasia could con-
ceivably be due to progenitor depletion through accelerated
differentiation. To verify this we analyzed the pancreas at E11.5
and observed that the remnant pancreatic tissue in Ngn3 ON
pancreas consisted predominantly of glucagon-positive (Gluþ)
cells, most of which expressed Pdx1 at low to intermediate levels
(Fig. 1E). Such cells were not proliferative as judged by absence of
M-phase activity (pHH3 staining, Fig. 1E). The WT pancreas
displayed ubiquitous Pdx1 expression and cells were proliferating
(Fig. 1D). Ngn3 expression was detected in the DTG pancreas,
throughout the central clustering of glucagon-expressing endo-
crine cells (compare Fig. 1E–G). Almost absolute progenitor
depletion was observed. A complete loss of the progenitor and
later acinar marker CPA1 was prominent (Fig. 1I) and Sox9
expression was essentially abrogated (Fig. 1K). We also found
no evidence of Muc1 expression (Fig. 1I). Mucin1 expression
reveals the initial emergence of tubulogenesis through microlumen(A) Schematic outline of the experiment. (B and C) Dissected mid-gut region, E18.5
agenesis is observed, including gastric/duodenal disjunction, with end-capping of
region at E11.5, using markers shown. (D and E) Conversion of pancreatic Pdx1-
nied by mitotic arrest (pHH3, E). (F and G) Ngn3 is detected widely in the central
ident by loss of carboxypeptidase A (CPA), (I), and Sox9 (K). Apically distributed
pancreas (L), as well as in DTG pancreas (M), overlapping regions also expressing
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(Kesavan et al., 2009)). In agreement, Dolichos Biﬂorus agglutinin
(DBA), a more mature marker of pancreatic ductal cells, was not
expressed in either WT or DTG pancreas, in agreement with the fact
that terminal ductal cell differentiation had not commenced at E11.5
(Fig. 1J and K). The progenitor marker Nkx6.1 remained expressed at
high levels, throughout the DTG pancreas (Fig. 1M). In WT, Nkx6.1 is
at this stage becoming restricted to centrally-located progenitor cells,
and gradually diminishing in expression in outer-layer epithelial cells
(Fig. 1L). Thus far the phenotype observed here corroborates previous
published reports indicating that when expressed ectopically in the
pancreatic endoderm, at the onset of pancreas development, Ngn3
induces primarily a Gluþ endocrine fate. As indicated by Johansson
et al., this is because the early pancreatic endoderm is competent for
glucagonþ fate induction, and only becomes competent to differ-
entiate into insulinþ cells at E11.5 (Johansson et al., 2007). To
circumvent this and to facilitate the formation of insulinþ cells, weFig. 2. Effects of conditional activation of Ngn3 on early pancreatic development.
(A) schematic outline of the experiment and (B) qRT-PCR evaluation of the
conditional activation of Ngn3 in individual DTG embryos at E10.5 and E11.5,
compared to WT littermates. (C and D) Pdx1/DBA/Glucagon immunostaining,
E12.5. E,F, Sox9/DBA/Acetylated immunostaining, as labeled.used Dox to bypass the initial Ngn3-induced effects observed in the
Ngn3 ON model. We administered Dox through intraperitoneal (i.p.)
injections into the pregnant mouse at gestational day 7.5 (E7.5) and
E9.5, and isolated embryos at E10.5, E11.5 and E12.5 (Fig. 2A and B).
The kinetics of Ngn3 induction was assessed by qRT-PCR at E10.5 and
E11.5. We did not observe an increase in total Ngn3 mRNA at 24 h
post-Dox administration (E10.5), but at 48 h (E11.5), total levels of
Ngn3 mRNA was 6.8-fold increased, compared to WT (Fig. 2B). These
Pdx1-tTAKI;pTRE2-Ngn3 DTG embryos receiving Dox at E7.5 and E9.5
are in the following referred to as Ngn3 Delayed ON embryos. The
histology of E12.5 Ngn3 Delayed ON pancreas resembled that of WT
pancreas, displaying uniform Pdx1 and Sox9 expression (Fig. 2D–F).
Epithelial cells were proliferative in both WT and Ngn3 Delayed ON
pancreas as assessed by BrdU incorporation (data not shown). The
excessive formation of Gluþ clusters causing progenitor depletion
observed in Ngn3 ON embryos was not prevalent (Fig. 2D). All Ngn3
Delayed ON embryos, at all stages analyzed successfully bypassed the
apancreatic phenotype of the Ngn3 ON condition (example shown
in Fig. 3C).
Overexpression of Ngn3 prior to the secondary transition results in
the induction of pancreatic duct cells
With the right Doxycyline administration required to achieve
Ngn3 overexpression at E11.5 established we were interested
in the differentiation abilities of Ngn3 Delayed ON pancreas. Were
such able to exclusively generate endocrine cells that were predomi-
nantly insulinþ as previously reported by Johansson et al. Johansson
et al. (2007). To address this, we analyzed E14.5 Ngn3 Delayed ON
pancreas (Fig. 3A and C). At E14.5, Ngn3 Delayed ON embryos
developed signiﬁcant pancreatic tissue, of both dorsal and ventral
origin (Fig. 3C). Surprisingly, histological analysis revealed an
expanded tubular network of b-catenin-expressing cells, interspersed
with few cells expressing Nkx6.1 (Fig. 3E). There was a noticeable lack
of epithelial branching and a general absence of forming acini at
epithelial tips (Fig. 3D and E). The reduction of Nkx6.1 indicated that
the epithelial cells were not of a progenitor type. This was conﬁrmed
by using markers of terminally differentiated cells, as the epithelial-
derived pancreatic tissue of Ngn3 Delayed ON (E14.5) consistedmainly
of two types of cells: glucagon expressing endocrine cells (Fig. 3I and
M) and DBA-expressing ductal cells (Fig. 3G). The dramatic increase in
relative cell areas of Gluþ and DBAþ cells were offset by reductions
in acinar and insulinþ cells (Fig. 3I, M and N), and agreed with the
general absence of Nkx.6.1 expression. Acinar cells (amylaseþ) were
largely absent (Fig. 3I and N), but present in WT (Fig. 3H); and
insulinþ cells were similarly almost completely absent (Fig. 3M and
N) but present in WT (Fig. 3L and N).
The 17-fold increase in ductal cell differentiation (Fig. 3N) was
surprising, and the DBAþ cell population outnumbered that of
the endocrine cells (Fig. 3G and I). To further clarify the pheno-
typic state of the ductal cells induced by Ngn3, we analyzed the
expression of Hnf1b, encoded by Tcf2. Hnf1b initially overlaps
with Nkx6.1 and Pdx1 within pancreatic progenitors (Maestro
et al., 2003) but only ductal cells continue to express Hnf1b
following differentiation. In Ngn3 Delayed ON E14.5 pancreas, we
observed that the cuboidal-epithelial DBAþ expressing cells were
Hnf1bþ , and ciliated as noted by presence of ciliary basal bodies
positive for acetylated tubulin (data not shown). This cellular
phenotype is identical to that of normal pancreatic ductal cells.
These ductal cells did not express Ngn3 (Fig. 3K).Ectopic Ngn3 expression leads to lateral induction of Notch signaling
The degree of ductal cell differentiation was both unexpected
and undesired. To elucidate the molecular underpinnings of this
Fig. 3. Delayed activation of Ngn3 induces pancreatic endocrine and ductal cell formation. (A) Schematic outline of the experiment. (B and C) Dissected mid-gut region
containing stomach (st), spleen (sp), dorsal pancreas (dp), ventral pancreas (vp) and duodenum (duo). Pancreas tissue is pseudo-colored in green. (D–M)
immunoﬂuorescence analysis of E14.5 WT pancreas and Ngn3 Delayed ON littermate using markers as shown. Inset in (L) shows the presence of mature Pdx1þ/insulinþ
cells in WT pancreas. (N) Morphometric analysis of relative cell areas of DBA, glucagon, amylase, insulin, compared to WT littermates (n¼3/condition).
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ON pancreas at E12.5. We employed qRT-PCR to screen a panel of
molecular markers for differences between the Delayed ON
pancreas and WT. On average total Ngn3 mRNA was increased
9.1-fold over WT. Attesting to the functional ability of ectopic
Ngn3 protein, we noted a signiﬁcant activation of Ngn3 target
genes, including NeuroD1, Pax4, Pax6 and Arx (Fig. 4A). Only a
modest (1.2-fold) increase in glucagon (Gcg) mRNA expression
was detected, but insulin (Ins) was not expressed at signiﬁcant
levels in WT, or DTG pancreas at this stage. Despite the increase
in total Ngn3 level, we were surprised to ﬁnd that endogenous
Ngn3 expression was attenuated to 20% of WT levels. A possible
explanation for the reduced expression of endogenous Ngn3 could
be increased activity of Notch signaling. We addressed expression
of the Dll1 gene, which has been identiﬁed as a target of Ngn3
(Treff et al., 2006; Gasa et al., 2004). Dll1 expression was
signiﬁcantly increased (2.4-fold compared to WT) (Fig. 4A). A
similar increase was noted in the Notch target gene Hes1, which is
critical for pancreatic development (Jensen et al., 2000), whereas
expression of multiple other hairy/enhancer-of-split family mem-
bers were unchanged (data not shown).The observed increased expression of the Notch ligand Dll1,
and the Notch target Hes1, argued for general elevation of Notch
signaling. To investigate the cellular subset able to promote Notch
signaling in the pancreas, as well as the recipient population,
we performed Ngn3/Dll1 co-expression analysis. Intensity of
membrane-associated Dll1 protein was strongly elevated in E12.5
(Fig. 4C) pancreas, compared to WT (Fig. 4B). Qualitatively, the
expression of Dll1 in the basal-membrane was similar between WT
and DTG pancreas. Dll1 was expressed by Ngn3-expressing cells,
however, it was also detectable in Ngn3-negative cells, adjacent to
Ngn3-positive cells. Considering that the total number of Ngn3-
expressing cells only represented a subset of epithelial cells these
data argue that cell-extrinsic activation of Notch signaling is a
consequence of the experimental elevation of Ngn3, and that Dll1 is
a plausible mediator.
Ngn3 is capable of promoting the pancreatic trunk ﬁeld prior to onset
of terminal ductal and endocrine differentiation
The increased expression of the Notch component genes
Dll1 and Hes1 was paralleled by a commensurate decrease in
Fig. 4. Ngn3 controls pancreatic patterning prior to the induction of terminal fates. (A) qRT-PCR analysis of select pancreatic genes. (B and C) Immunoﬂuorescence analysis
of Dll1 and Ngn3 WT and Ngn3 Delayed ON littermate at E12.5. (D and E) Similar, analysis of E-cadherin and Ptf1a. Ptf1a-expressing cells are located at the mesenchymal/
epithelial boundary (arrows, D) (F and G) expression of Nkx6.1 in WT and Ngn3 Delayed ON E12.5 pancreas differs qualitatively by the presence of Nkx6.1 expressing cells
at the epithelial/mesenchymal boundary (G). In WT pancreas, Nkx6.1 is at this time point excluded from distal cells (F). (H) morphometric analysis of relative cell areas of
Ptf1a and Nkx6.1, compared to WT littermates (n¼3/condition).
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reduced to 50% of WT levels, coupled with a more drastic
reduction in Cpa1 expression level (Fig. 4A). This was contrasted
by a sustained expression of the, at this time, epithelial progenitor
markers Krt19, and Hnf1b genes. But the expression of Sox9 was
reduced by 40%, suggesting a general loss of Sox9 mRNA, as the
protein expression remained qualitatively intact (Fig. 2F).
Although we did not ﬁnd evidence of increased terminal ductal
differentiation at this stage, a signiﬁcant increase in expression of
the Onecut-family member 2 (Oc2) was evident (Fig. 4A). Inter-
estingly, expression of the homologous gene Oc1 (encoding Hnf6,
a known regulator of Ngn3 expression), was signiﬁcantly reduced
to 20% of WT levels (Fig. 4A).
We and others recently reported the requirement of Notch for
patterning of MPCs towards pro-endocrine/duct (trunk) fate
(Afelik et al., 2012; Horn et al., 2012). The increased level of
Notch coupled with the reduction of pro-acinar markers in our
qRT-PCR analysis therefore prompted us to examine the tip-trunk
pattern in the Ngn3 Delayed ON pancreas with histology. We
addressed the creation of the pro-acinar ﬁeld. Ptf1a is a useful
marker, at E12.5 being conﬁned to distal tip cells contacting the
outer basal lamina of the epithelium (Fig. 4D). The nuclear
staining for Ptf1a was almost abolished in Ngn3 Delayed ON
pancreas (Fig. 4E). This loss was proportionate with a reduction
in staining for CPA1 (Fig. 4C), as well as amylase (not shown).Next, we addressed the creation of the trunk progenitor ﬁeld.
Nkx6.1 is a useful marker, as this becomes localized to the trunk
ﬁeld prior to E12.5 and is excluded from the distal tip ﬁeld (Fig. 4F
and (Jorgensen et al., 2007)). Nkx6.1 has been shown to operate
antagonistically to Ptf1a (Schaffer et al., 2010). Nkx6.1 was widely
distributed throughout the E12.5 Ngn3 Delayed ON pancreas
(Fig. 4G); expressed in cells analogous to a tip-position, at the
epithelial/mesenchymal border. Morphometrical analysis con-
ﬁrmed the relative shift between the Nkx6.1 and Ptf1a trunk/tip
markers (Fig. 4H). We conclude that ectopic Ngn3 expression
elicited a shift towards Nkx6.1 expression, with a concomitant
loss of Ptf1a expression, and hereby distorts the TrPC/TipPC
pattern that normally segregates multipotent pancreatic progeni-
tors prior to the secondary transition (Schaffer et al., 2010; Zhou
et al., 2007).
We were interested in the differentiation status of the Ngn3-
expressing cells in the Delayed ON condition. In this model, Ngn3
expression would almost exclusively be transgene-driven, as the
endogenous Ngn3 gene was effectively suppressed (Fig. 4A).
Do such cells represent Ngn3þ expressing progenitors, or alter-
natively partially differentiated, yet lineage-committed endocrine
cells? To evaluate this, we performed co-expression analysis of
Pax6 and Ngn3 (supp. Fig. S2). Pax6 is an early, endocrine-speciﬁc
marker associated with post-mitotic endocrine cells irrespective
of sub-type, and is therefore a lineage commitment marker.
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analyzed (E11.5, E12,5, and E14,5) were not co-expressing Pax6,
except for very rare cells (example shown in supp. Fig. S2D).
Clustered Pax6þ/Ngn3 cells were present in both WT, and
Delayed ON DTG pancreas, showing that in both situations;
endocrine cell formation is associated with a loss of Ngn3 in the
post-mitotic endocrine descendant. Because the endocrine com-
plement of the Ngn3 Delayed ON pancreas lacks Pdx1-expressing
beta-cells (Fig. 3M), this also explains the lack of Pax6/Ngn3
double-positive cells in the DTG pancreas.
Differential ability of Ngn3 in the induction of endocrine versus
ductal fate
The Ngn3 Delayed ON phenotype when analyzed at E14.5 and
E12.5 differed substantially. When analyzed at E12.5 we detected
signiﬁcant levels of Ngn3 expression, yet at E14.5, Ngn3 protein
was substantially reduced. Because the cell complement observed
at E14.5 consisted of differentiated cells, whereas at E12.5, we
found that most cells were of a pancreatic progenitor type,
patterned towards the TrPC type, these data argued that TrPC’s
had executed a terminal fate selection in the period of
E12.5–E14.5. We were interested if this event required ongoing
transgenic Ngn3 expression. To clarify, we administered Dox to
Pdx1-tTAKI;pTRE2-Ngn3 pregnant females at E7.5, E9.5 as well as
at E12.5, followed by analysis at E14.5 (supp. Fig. S3A). The time-
window for transgenic Ngn3 expression would thus be limited to
a brief period between E11.5 and E12.5. These embryos are
referred to as Ngn3 Brief ON, (supp. Fig. S3B K). In this experiment,
the formation of pancreatic endocrine cells was not prevalent, yet
we noted a reduction in acinar cell formation (CPA1þ , Ptf1aþ ,Fig. 5. Notch/Hes1 controls Ngn3 protein stability. (A–H) Double immunoﬂuorescence
E13.5 (A–C and E–G), and Ngn3 Delayed ON pancreas at E11.5 (D and H). White arrows
negative epithelial-type cells. (I) Protein stability and half-life assessment of Ngn3 in He
with Doxycycline for 24 h, and on the subsequent day pre-exposed to the proteaso
cycloheximide (CHX). Western blot using anti-Ngn3 antibodies are shown; b-actin s
accumulation at t¼0, and strongly stabilizes the protein, which rapidly decays in non-tr
Notch1 and Notch2 intracellular domains (N1ICD, N2ICD respectively) (left), or dominan
The left-most blot is overexposed to reveal the lower level of accumulated Ngn3 prot
analysis was done 1 h post CHX treatment. The right-most blot shows the relative increa
pancreatic E14.5 explants were subjected to short-term treatment of CHX (1 h) and
subjected to anti-Ngn3 Western blotting. Levels of Ngn3 increase in presence of MG132
presence of DAPT, a condition where the protein remains stable (CHXþDAPT lane). (
proteins. The experiment was conducted as in I and J. Decay scans (right) provide a m
treatment is paralleled by the relative half-life of the protein. Destabilizing conditions
DAPT-treatment. C-terminally truncated Hes1 (Hes1DC), and Skp2 presence do not affesupp. Fig. S3C, E and L), as well as increased ductal formation
(DBAþ , Hnf1bþ (supp. Fig. S3C, G, I and L)), although not as
prominent as observed in the E14.5 Delayed ON embryos. Gluþ
cells were only modestly increased in density (1.4-fold) (supp.
Fig. 3K and L), compared to the approximate 35-fold induction
observed in the Ngn3 Delayed ON E14.5 pancreas (Fig. 3N). Also,
only rare insulinþ cells were detected (Supp. Fig. S3G and L).
Expanded trunk regions expressing Pdx1 was found (supp. Fig. S3I
and K). Ngn3-expressing cells were identiﬁed in the trunk regions
(supp. Fig. S3G), and given the experimental administration of
Doxycycline post-E12.5 in the Brief ON experiment, these cells are
presumably expressing the endogenous Ngn3 protein, in accor-
dance with the trunk being competent for Ngn3 activation.
Agreeing with the Ngn3 delayed ON model ductal induction was
found to be disproportionately higher than the induction of Gluþ
cells under these conditions as based on morphometrical assess-
ment (supp. Fig. S3L). This experiment demonstrates not only that
continuous expression of Ngn3 is needed for complete TrPC
patterning of the MPC pool, as suggested previously (Wang
et al., 2009), but also that a brief exposure of Ngn3 expression
is less effective in the induction of endocrine fate, as compared to
its ability to induce of ductal cells. Indirectly, this experimental
outcome is in agreement with a threshold mechanism of Ngn3 in
the induction of endocrine fate, as also suggested previously
(Wang et al., 2010).
Preservation of the dynamics of Hes1/Ngn3 expression, and
consequently lateral inhibition, during ectopic Ngn3 expression
In the developing pancreas, the expression of Ngn3 and Hes1
are mutually exclusive and the outcome of previous targetedanalysis of Sox9/Hes1 (A–D), and Ngn3/Hes1 (E–H) of WT pancreas from E11.5–
in (E) and (F) denote Ngn3þ cells. Yellow arrows in (G) denote Ngn3/Hes1-double
pG2 cells. HepG2 cells were transfected with pTRE2-Ngn3 and pCMV-rtTA, treated
mal inhibitor MG132 for 5 h. At time t¼0, protein synthesis was inhibited by
erved as a control, and remains stable. MG132 treatment leads to Ngn3 protein
eated cells. (J) Experiment conducted similarly as in (I), but CMV-driven versions of
t-negative mastermind-like1 (DN-MAML1) were co-transfected with pTRE2-Ngn3.
ein in presence of N1ICD, N2ICD, and the loss of Ngn3 upon CHX treatment. The
se in Ngn3 protein in cells expressing DN-MAML1; Ngn3 remains stable. (K) Mouse
MG132 (5 h pre, and post-culture) as indicated. Total protein was isolated and
, and decrease in response to CHX. Ngn3 protein levels increase correspondingly in
L) Stability measurements of Ngn3 in the presence of various cellular regulatory
easure of the decay rate of Ngn3. In all cases, the t¼0 Ngn3 levels prior to CHX
include N1ICD, N2ICD, and Hes1. Stabilizing conditions include DN-MAML1 and
ct Ngn3 stability. Hes1 is able to destabilize Ngn3 in the presence of DN-MAML1.
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suggest that Ngn3 cells are engaged in lateral inhibition with Notch-
active (Hes1þ) cells (Apelqvist et al., 1999; Jensen et al., 2000). We
therefore wondered if the induction of Hes1 through Ngn3 over-
expression would result in Ngn3þ/Hes1þ double-positive cells,
as the driving promoter (Pdx1) for the transgenic system should
be refractory to lateral inhibition and could such cells account for
the unexpected ductal phenotype? To do this, we carried out
co-immunostaining of Ngn3 and the oscillatory Notch-target Hes1
(Hirata et al., 2002) and also related the expression of Hes1 to the
progenitor marker Sox9. In WT pancreas, Hes1 protein is expressed
heterogeneously but widely throughout the progenitor pool at E11.5
(Fig. 5A). This expression always overlaps with Sox9 (Fig. 5A),
although Sox9 is more homogenously expressed, in agreement with
Sox9 being upstream of Hes1 (Seymour et al., 2007). This pattern
exists prior to the emergence of Ngn3þ cells in WT pancreas
between E11.5–E13.5 (Fig. 5A–C). Consequently, Hes1 is expressed
dynamically in individual progenitor cells prior to Ngn34Dll14
Notch lateral signaling, and implies that Notch signaling is engaged
prior to normal onset of Ngn3 expression at the secondary transition
at E13.5. In WT, the numbers of Ngn3þ cells gradually increase over
E11.5–E13.5 (Fig. 5E G), decreasing thereafter (not shown). At these
time points, Ngn3 is always reciprocally expressed with Hes1,
in agreement with the mechanism of lateral inhibition. At E13.5,Fig. 6. Notch signaling inhibition promotes beta- and acinar-cell formation, at the exp
were cultured for 4 days in the absence/presence of 100 mM DAPT. Sections were sta
analysis of explants performed as in (A) and (B). Pancreatic marker genes were assessed
method, using GAPDH mRNA as internal standard. (D–K) Ngn3 Delayed ON pancreas (E12
to 4 days of explant culture with and without DAPT as described in (A) and (B). Immu
4 days in culture. (D’) Inset image showing the expression of glucagon, blue.Hes1-negative/Ngn3-negative cells are found, likely corresponding to
differentiated cells (Fig. 5G, yellow arrows). Analyzing Ngn3 Delayed
ON pancreas at E11.5, the Sox9/Hes1 expression pattern remained
qualitatively intact compared to WT (Fig. 5D). Yet, the number of
Ngn3þ cells (which are mainly derived from TG production, as
endogenous Ngn3mRNA is effectively reduced, Fig. 4A) wasmarkedly
increased at E11.5 as compared to WT pancreas as expected.
Surprisingly, Ngn3 and Hes1 remained reciprocally expressed
(Fig. 5H), qualitatively similar to WT at E13.5 (Fig. 5G).Notch signaling controls Ngn3 protein stability
While Hes1 is known to directly inhibit Ngn3 expression
transcriptionally (Lee et al., 2001), this would be an insufﬁcient
explanation for the observed results in which Ngn3 was driven by
a Pdx1-tTA;tetO governed system. Therefore, the lack of homo-
genous Ngn3 protein expression in the DTG pancreas strongly
suggested that Notch-mediated lateral signaling negatively con-
trols Ngn3 protein. As destabilization of other bHLH factors,
including NGN, and hASH1 has been observed (Vosper et al.,
2007) which have also implicated Notch (Sriuranpong et al.,
2002), we then tested if a similar mechanism might operate in
the pancreas. As a means to mechanistically address this question,ense of ductal cell development. (A and B) Mouse WT pancreatic explants (E12.5)
ined against Mucin1, carboxypeptidase1 (CPA) and glucagon (Glu). (C) qRT-PCR
and fold-changes to WT explants treated with DMSO were calculated by the DDct
.5, doxycycline was provided at E7.5, E9.5 as in Fig. 2A) was isolated and subjected
noﬂuorescence analyses of explant pancreas using select pancreatic markers, after
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different heterologous cell lines (HepG2, Hek293, and CHO) condi-
tionally expressing Ngn3, we observed a rapid decay of Ngn3 protein
when further protein synthesis is blocked by addition of cyclohex-
imide (CHX); control protein, beta-Actin, remained stable under these
conditions (Fig. 5I and data not shown). As the Notch signaling
pathway is involved in growth control of HepG2 cells, and because
these cells express Delta1, Jagged1, Notch3 ICD, and Hes1
(Suwanjunee et al., 2008), we chose the HepG2 cell line for more
detailed studies. Through time course experiments after addition of
CHX, we deﬁned the half-life of Ngn3 to be very short (T1/2300)
(Fig. 5I), comparable to T1/2 values for Ngn1, and Mash1, as shown by
others. Exposure of Ngn3 expressing HepG2 cells to the proteasomal
inhibitor MG132 stabilized the protein, T1/243h (Fig. 5I), suggesting
that Ngn3 half-life is regulated by proteasomal activity. We then
tested if Notch signaling played a role in Ngn3 protein accumulation
and Ngn3 degradation in HepG2 cells by co-expression of the Notch1,
or Notch2 intracellular domains (N1ICD, N2ICD, Fig. 5J and L). In the
presence of Notch ICDs, Ngn3 protein failed to accumulate (Fig. 5J),
and the measured T1/2 of Ngn3 was extremely short (T1/2o150,
Fig. 5L). Investigating if transcriptional regulation was required
downstream of Notch processing, we co-transfected a dominant
negative version of the prerequisite Notch signaling co-activator
Mastermind-like-1 (DN-MAML1). This completely abrogated the
ability of Notch in destabilizing Ngn3, and furthermore led to a
marked increase in total amounts of Ngn3 produced in the HepG2
cells (Fig. 5J and L). We conclude that the basal turnover of Ngn3 in
the HepG2 line was mainly conferred by the ongoing Notch signaling
in those cells; a ﬁnding conﬁrmed by an increase in total Ngn3
protein levels—with a commensurate protein stabilizing effect in the
presence of the Notch inhibitor, N-[N-(3,5-diﬂuorophenacetyl)-1-
alanyl]-S-phenylglycine t-butyl ester (DAPT) at 50 mM (Fig. 5L, and
data not shown). It could be argued that the mechanistic insight
derived from the HepG2 studies was cell culture speciﬁc, but E14.5
mouse pancreatic explant studies (WT) using CHX and DAPT revealed
that endogenous Ngn3 protein was indeed rapidly turning over due
to proteasomal degradation, as this loss was abrogated by exposure
to MG132 (Fig. 5K). Interestingly, exposure of explants to DAPT led to
similar levels of Ngn3 protein stability as in pancreatic explants
treated with the proteasomal inhibitor MG132 over the same time
course (Fig. 5K). Given that the Ngn3 protein stability conferred by
DAPT alone is comparable to that of MG132 treated pancreas, we
conclude that Notch signaling is the predominant regulator of Ngn3
protein stability in the E14.5 normal mouse pancreas, possibly
priming Ngn3 for subsequent proteasomal degradation.
While the mechanism linking Notch signaling to Ngn3 degrada-
tion is unknown, one possibility could be through Notch mediated
induction of Skp2 expression. Skp2 encodes an E3-ubiquitin protein
ligase that has been shown to be activated by Notch. However,
overexpression of Skp2 protein did not affect Ngn3 turnover. In
contrast, overexpression of Hes1 protein led to destabilization of
Ngn3, with almost identical kinetics as observed with N1ICD, or
N2ICD (Fig. 5L). Deletion of the C-terminal domain of Hes1 abro-
gated this effect (Fig. 5L). To ascertain if Hes1 was able to control
Ngn3 turnover in absence of transcriptional events downstream of
active Notch, we over-expressed DN-MAML1 in the presence of
Hes1. While DN-MAML1 led to a marked increase in total Ngn3
protein as expected, Hes1 remained able to destabilize Ngn3
(Fig. 5L). Consequently, Hes1 is-independent of other transcriptional
events elicited by Notch-able to control Ngn3 degradation.
Induction of Notch signaling is the underlying molecular mechanism
for Ngn3-mediated ductal cell differentiation
Our previous data did not allow us to formally discriminate
which molecular mechanism(s) account for the induction of ductalcells by Ngn3. Given that pancreatic ductal cells form in Ngn3 null
mice (Gradwohl et al., 2000), and because ductal genes have not
been identiﬁed as direct Ngn3 targets, we set forth to determine if a
cell-extrinsic mechanism involving Notch indeed was causal for the
duct cell induction observed in Ngn3 Delayed ON pancreas. We ﬁrst
tested if pancreatic ductal cell differentiation was dependent on
Notch. We cultured WT pancreatic explants in the presence of DAPT
(Fig. 6A–C). These experiments were based on E12.5 pancreas, as at
that age, the majority of tip/trunk patterning has occurred, and cells
are actively undergoing terminal fate decisions. These cultures
developed signiﬁcant numbers of Muc1þ ductal cells during culture
in absence of DAPT (Fig. 6A), with a density exceeding that found in-
vivo. Acinar cell development (CPA1þ) proceeded in WT (Fig. 6A),
albeit at a much reduced level compared to normal development. In
the presence of 25–50 mM DAPT, ductal cell development was
signiﬁcantly reduced, and fully abolished at 100 mM DAPT addition
(data not shown, and Fig. 6B). Given that Notch processing inhibition
strongly affected cellular differentiation, we investigated this further
by performing qRT-PCR on similar-type explants (Fig. 6C). As shown
by others, Notch signaling inhibition led to quite dramatic increases
in endocrine cell differentiation (dose-dependent increases observed
for Ngn3, NeuroD1), and it also strongly promoted acinar gene
expression (Cpa1, Cpa2, Ptf1a). However, variable effects on endo-
crine subtypes was noted, where at high levels of DAPT (100 mM),
Gcg expression was reduced, while Ins1, Ins2 was further enhanced.
In agreement with the increased levels of Ins1and Ins2, Nkx6.1 was
also elevated, here reﬂecting the association of Nkx6.1 with the
mature beta cell, rather than the TrPC. This notion is supported by a
commensurate reduction of other TrPC marker genes, such as Sox9
and Hnf1b (Tcf21) The loss of Oc2indicate loss of ductal fate, in
agreement with the observed reduction of Muc1þ ductal cells
(Fig. 6B).
Given that Dll1 and Hes1 were 42-fold increased in the E12.5
Ngn3 Delayed ON pancreas, we next asked to what degree Notch
processing was also required for the enhanced Ngn3-mediated
ductal cell formation in that model. Similar to above, micro-
dissected E12.5 Ngn3 Delayed ON pancreas was cultured for 4 days
ex-vivo with and without DAPT (Fig. 6D–K). In contrast to WT
explants, Ngn3 Delayed ON pancreas developed in a quite similar
manner as observed in-vivo; in addition to widespread ductal
formation, glucagon-producing clusters were observed, and extre-
mely few acinar cells were found (Fig. 6D, F and H). Similar results
were obtained using staining for Hnf1b (data not shown). As
observed for WT pancreas, acinar density (CPA1þ cells) was
much increased upon DAPT treatment (Fig. 6E and G). The
Ngn3-mediated ductal cell formation was abrogated by DAPT
treatment (Fig. 6E, G and I). Of note, numerous Pdx1þ/Insþ
endocrine cells were observed upon DAPT treatment (Fig. 6K),
while glucagon-expressing cells (normally encountered at signif-
icant numbers in non-DAPT treated Ngn3 Delayed ON pancreas,
Fig. 6D, H and J) were correspondingly reduced (Fig. 6E, I and K).
We conclude that Notch signaling is required for both normal, as
well as Ngn3-mediated, pancreatic ductal cell development, and
that blocking this pathway promotes acinar and endocrine fates
at the expense of ductal cells. Of note, at high levels of DAPT
treatment, g-secretase inhibition impacts endocrine subtype
determination as well, and if a concomitant increase in Ngn3
protein is provided, the organ regains capacity for signiﬁcant
insulin-cell differentiation.Discussion
We have here elucidated an ability of Ngn3 in promoting
pancreatic ductal cell formation based on the capacity of Ngn3 in
creating a bipotential trunk ﬁeld via Notch signaling. Loss-of
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the gene in the development of all pancreatic endocrine cells
(Gradwohl et al., 2000) and the current perspective of Ngn3
function pivots around this role in the early endocrine lineage
determination. Our data is in agreement with a mechanism by
which Ngn3 is capable of inducing endocrine cell formation
provided it exceeds a repressive threshold for differentiation set
by Notch/Hes1 signaling. Ngn3 expression is able to exert dra-
matic changes to organ development when expressed prior to its
normal induction window resulting in endocrine terminal fates at
the secondary transition. We conﬁrm that elevated Ngn3 expres-
sion activates endocrine progenitor genes (Arx, Pax4, NeuroD)
prior to terminal differentiation, and this support a cell-intrinsic
effect of Ngn3 on endocrine differentiation. Yet, this simple linear/
causal relationship between Ngn3 activity and the endocrine fate
fails to capture important dynamics of Ngn3 upon the Notch
signaling system. This also inadequately describes the dynamics
of Ngn3 protein stability as controlled via Notch/Hes1. Our data
demonstrate that overexpression of Ngn3 can elevate Notch/Hes1
signaling, which in turn not only affects the compartmentaliza-
tion of the progenitor domain as an initial event, but subse-
quently negatively inﬂuences the endocrine differentiation
process in the majority of such endocrine/ductal progenitors. This
mechanism explains the rapid dynamic changes in expression of
opposing bHLH factors (Ngn3, Hes1) that either suppress (Hes1)
or promote (Ngn3) cell differentiation. Understanding that the
foundation of this bilateral system rests on control of Ngn3
protein stability is clearly relevant while seeking to optimize
endocrine cell induction. Our data using pancreatic explants
provides a ﬁrst line of evidence that the largely undesired lateral
ductal fate induction occurring due to Ngn3 expression can be
successfully circumvented by modulation of Notch signaling.
Ngn3 impacts Notch signaling and affects pancreatic progenitor
trunk-ﬁeld patterning
Our ﬁndings reveal that conditional activation of a pro-
endocrine drive leads to very different outcomes dependent on
gestational time. If this occurs at time of budding, multipotent
progenitor cells (MPCs) will adopt a glucagon-expressing fate, and
MPC depletion ensues, with an almost apancreatic phenotype as
a result. Conditional activation of Ngn3 at a later stage, as in the
Ngn3 Delayed ON model, leads to suppression of acinar fate, but
MPCs are capable of adopting both endocrine and duct fates.
While we were initially surprised in ﬁnding that the predominant
terminally differentiated cell type was a ductal, rather than an
endocrine one, upon delayed Ngn3 expression, this outcome is in
agreement with more recent investigations into the spatial and
temporal role of Notch in pancreas. Our data suggest that
increased Ngn3-expression leads to Dll1 expression, and thus
activation of Notch hereby impacting TrPC formation. Thus, the
phenotype of Ngn3 gain-of-function is a composite of cell intrin-
sic (endocrine differentiation) and cell-extrinsic events (via Notch
activation leading to a MPC4TrPC patterning change). When
Ngn3 expression is elevated prior to induction of terminally
differentiated endocrine cells, Ptf1aþ cells are lost, whereas
Nkx6.1þ cells expand. The Ptf1a/Nkx6.1 pair is antagonistic to
each other and the relative expression of the two factors deter-
mine tip/trunk ﬁeld establishment in multipotent progenitors
(Schaffer et al., 2010).
The more recent role of Notch in progenitor patterning begs
mechanistic comparisons to the previously described role of
Notch in lateral inhibition. Lateral inhibition involves the reci-
procal signaling between adjacent multipotent progenitors gov-
erning the eventual endocrine fate outcome. This mechanism has
been considered relying on transcriptional repression but this isan incomplete explanation considering the impact of Notch on
Ngn3 protein half-life as described here. Notwithstanding, lateral
inhibition also fails to provide an adequate picture of the role of
Notch as this pathway impacts the segregation of multipotent
progenitor cells into tip/trunk positional ﬁelds prior to their
terminal fate allocation; a process originally described by Zhou
et al. Zhou et al. (2007). While the possible patterning role of
Notch was initially discovered during studies of Presenilin (Ps1/
Ps2) mutants, where a surprising fate switch of Ngn3-expressing
cells into the acinar lineage was observed (Cras-Meneur et al.,
2009), more recent data provided direct evidence. Expression of
NICD in Pdx1þ cells induced expression of the TrPC patterning
marker Nkx6.1 (Schaffer et al., 2010). Complementing this ﬁnding,
we observed that pancreatic MPCs conditionally experiencing
Notch signaling inhibition through expression of DN-MAML1
became competitively disadvantaged against WT cells in adopting
a trunk-type identity at the time of compartmentalization (E11.5–
E12.5), and we showed that the RBPjK factor was directly bound
to the Nkx6.1 regulatory region (Afelik et al., 2012). Further
functional evidence for a role of Notch in MPC4TrPC patterning
was obtained from studies of Mindbomb and conditional Hes1
mutants, revealing a requirement of Notch signaling in the
development of TrPC-descendant ductal and endocrine cells
(Horn et al., 2012), and this process appear to occur through a
process of Sox9 maintenance from a Notch-active pool (Shih et al.,
2012). Together, these data suggest that prior to the secondary
transition, and thus prior to normal Ngn3 activation, Notch
signaling is ongoing and serves to pre-pattern MPC towards a
bi-potential endocrine/ductal progenitor type.
Notch signaling and the gestational control of endocrine subtype
determination
Our initial motivation for investigating Ngn3 through a novel
conditional activation model was to gain insight into the mole-
cular mechanisms that may help explain why the competence
of the Ngn3-expressing populations changes so dramatically with
gestational age (Johansson et al., 2007). At early pancreatic
development, Ngn3-expressors are competent for acinar fate,
yet such competence is lost over time. The competence for
beta-cell fate is not reached until E12.5, whereas earlier time
points, most endocrine cells that develop in response to Ngn3 are
of a glucagon-expressing type. Our data suggests that both these
time-dependent changes in competence is a response to the
degree of Notch signaling in the MPC pool. Because acinar
competence depends on TipPC patterning, then, as the bipotential
pro-endocrine/ductal TrPC forms between E11.5–E12.5 it is to be
expected that Ngn3-expressing cells lose acinar competence as
the pancreas reaches the E12.5 stage. Regarding the endocrine
competence dynamics (beta-cell formation), a similar argument
can be posited. Using explant studies, we observed the emergence
of pancreatic beta cells from Ngn3 Delayed-ON pancreas, upon
providing DAPT after the TrPC patterning effect of the transgene
had been established. One possibility explaining endocrine gesta-
tional dependency is that beta-cell competence is related to TrPC
formation and that this is at least partially explained through
Notch activation of Nkx6.1. It is well known that Nkx6.1 is critical
for beta cell function in the adult state and it is also involved in
beta cell formation during embryonic stages. Relevant questions
emerge such as how Nkx6.1 presence may impact the alpha/beta
cell subtype switch that is controlled by relative Pax4/Arx expres-
sion? Also, could Notch/Hes1 be involved in controlling the Pax4/
Arx dynamics in a more direct manner? While our data does not
speciﬁcally address the importance of duration of Notch signal-
ing it is possible that Notch-mediated epigenetic changes,
accumulating over time, could be involved development of beta
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determinant loci, including Nkx6.1. If so, the prolongation of
Notch activation, rather than total level of induction, could be
critical. Some of these emerging opportunities might inﬂuence
the differentiation strategies of pluripotent cells towards the beta
cell fate.
Notch-mediated control of bHLH complex formation via effects on
protein stability
We uncovered a novel post-transcriptional involvement of Notch
signaling negatively controlling Ngn3 protein. The current basis for
understanding lateral inhibition in pancreas, as well as elsewhere,
largely centers on cross-repressive transcriptional control. Tran-
scriptional repressive systems are known in somitogenesis, as well
as neurogenesis, and the current paradigm is that Notch-driven Hes-
class protein production leading to repression of transcription of
various lineage-speciﬁc bHLH genes, such as Ngn3 in pancreas (Lee
et al., 2001). For instance, in the Ngn3 Delayed ONmodel, there is an
almost complete abrogation of expression of endogenous Ngn3
mRNA, as would be expected through transcriptional repression of
Ngn3 by Hes1 (Fig. 4H). In addition, we now uncover that Notch-
controlled proteolysis of Ngn3 also occurs. Similar results have been
described for Notch-induced ubiquitination and degradation of
hASH1 (Sriuranpong et al., 2002), E2A (Nie et al., 2003), and TAL/
SCL (Nie et al., 2008). These bHLH factors have demonstrated half-
lives o30 min and Ngn3 is in a similar range. Given that Hes1 is an
unstable protein in all contexts analyzed, we propose that Ngn3 and
Hes1 may operate as an ultradian pair in the pancreas because their
expression is always mutually exclusive in the WT organ (Fig. 5E–G)
and remain so in the Ngn3 TG model as well (Fig. 5H). An ultradian
model have been applied to the developing nervous system helping
to explain howmultipotent neural progenitors remain uncommitted
when pro-neural genes are transcriptionally active (Shimojo et al.,
2008; Kageyama et al., 2009; Kobayashi et al., 2009). An ultradian
model might help explain the observed fate plasticity in the
pancreas, notably when Notch signaling is active (Murtaugh et al.,
2003), but the experimental evidence would require time-lapse
studies of ﬂuorescently detectable versions of Ngn3 and Hes1,
currently unavailable.
While it remains undetermined how Notch signaling causes
Ngn3 protein degradation, we speculate that complex formation
between bHLH factors such involving in particular Hes1, could be
important. Hes1 overexpression reduces the T1/2 of Ngn3 almost
comparatively to N1ICD, or N2ICD, and we found no evidence that
Skp2, as a candidate Notch-induced E3 ubiquitin ligase (Nie et al.,
2008; Dohda et al., 2007), reduced the stability of Ngn3. Impor-
tantly, Hes1 retains the ability to induce Ngn3 degradation in the
presence of DN-MAML1 inhibition of Notch-induced transcrip-
tional activation. It may be possible that Hes1-mediated tran-
scriptional repression of unknown targets could be occurring.
However, this would add an additional delay that seems incom-
patible with the rapid degradation kinetics of Ngn3. Therefore,
it would be of interest to determine balances of possible bHLH
heterodimers between, Ngn3:Hes1 (should such exist, which is
currently unknown), E2A:Hes1 versus Ngn3:E2A, and testing the
relative stability of such in pancreatic progenitors. A simple
explanation to the observed Ngn3 degradation could be that if
Ngn3 is unable to ﬁnd a suitable E2A family partner then it is
degraded. If so, the essential role of Notch during lateral inhibi-
tion is speculatively to control the formation of Hes1-containing
bHLH complexes. In such a case, the Ngn3-based endocrine
commitment hereby becomes governed through stoichiometric
limitations so enforced via Notch induction of Hes1 protein.
Because Hes1 is a short-lived protein, rapid dynamic changes
to the bHLH balance are achievable. The emerging model isintriguingly comparable to the now classical studies involving
the balancing of bHLH complexes (Scute (aka Sisterless-B) versus
E(spl) class members and Deadpan) in the X/A-based numerator/
denominator mechanism during Drosophila cell-autonomous sex
determination, which controls the female activation of the spli-
cing regulator Sxl (Liu and Belote, 1995; Cline, 1993) during a very
narrow embryonic window.
Conclusive remarks
Towards clinical translational applications, our data is of
relevance to systems in which bHLH-class factors operate to
induce cell differentiation and where such are engaged during a
lateral signaling process. Clearly, many such systems may exist,
ranging from neural, muscle, and speciﬁc endoderm-derived
structures such as pancreas and intestine, and thus encompasses
cells in all germ layers. The use of particular bHLH factors
in directed differentiation and/or somatic cell conversion may
be viewed as a double-edged sword, as uncommitted cells are
plausibly prone to respond to lateral cues and attenuate the
desired cell fate induction through Notch/Hes-mediated degrada-
tion of the inducing protein. At ﬁrst glance, a particular strategy
would focus on providing the appropriate bHLH-type factor,
together with Notch signaling inhibition. At least for the pancrea-
tic system, this concept is problematic. The inhibition of Notch
would also lead to change in compartmentalization and a loss of
TrPCs. Conceptually, careful control of Notch signaling levels, as a
means to appropriately deﬁne progenitor competence and the
subsequently manipulate a ﬁnal binary fate choice emerges as a
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